Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Japanese Journal of Clinical Oncology|March 12, 2026
Real-world comparison of enzalutamide and apalutamide in metastatic hormone-sensitive prostate cancer: a multi-institutional propensity score-matched analysisKazuki Nishimura, Kensuke Hirosuna, Heima Niigawa, et al.
World Journal of Urology|February 24, 2025
Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score's impactTatsuo Fukushima, Takuya Tsujino, Moritoshi Sakamoto, et al.
Scientific Reports|July 27, 2025
Eosinophils as a predictive marker of treatment-related adverse events in mRCC patients treated with first-line immune-checkpoint inhibitor combination therapyTatsushi Kawada, Satoshi Katayama, Takafumi Yanagisawa, et al.
Anticancer Research|May 27, 2026
Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate CancerYasutaka Yamada, Marika Matsumoto, Mai Ikehara, et al.
International Journal of Clinical Oncology|January 31, 2025
Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortiumTaizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura, et al.
BJU International|November 13, 2025
Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosisTomoki Shirafuji, Yasutaka Yamada, Kodai Sato, et al.
International Journal of Clinical Oncology|October 29, 2024
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan ConsortiumTaizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura, et al.
Pageof 7